Headquarters
64 HOMER ST, NEWTON CENTER, MA 02459-1517, US
NEWTON CENTER, MA, US
From the company
Courage Therapeutics is a neuroendocrine company co-founded by Dr. Roger Cone that translates discoveries and novel chemistries into therapeutic candidates targeting the MC4R receptor. Its lead candidate, CTX-B, is a weekly injectable for the treatment of melanocortin-4 receptor haploinsufficiency (MC4R HI), a genetic obesity with no approved targeted therapeutic options.
64 HOMER ST, NEWTON CENTER, MA 02459-1517, US
Quantities, certifications, and timing.